AML: making residual disease more measurable

Blood. 2022 Aug 4;140(5):415-417. doi: 10.1182/blood.2022017138.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / genetics
  • Leukemia, Myeloid, Acute* / therapy
  • Neoplasm Recurrence, Local*
  • Neoplasm, Residual
  • Prospective Studies